Evaluation and Mechanistic Investigation of Antitumor Compounds from Dioscorea nipponica Makino subsp. rosthornii Through Spectrum-Effect Relationship Analysis - Scorecard - MDSpire

Evaluation and Mechanistic Investigation of Antitumor Compounds from Dioscorea nipponica Makino subsp. rosthornii Through Spectrum-Effect Relationship Analysis

  • By

  • Mengjia Liang

  • Moyu Shen

  • Yuxuan Wang

  • Pengxin Fan

  • Yuguang Zheng

  • Haiyang Wang

  • Jingcun Sun

  • Songsong Jing

  • April 29, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation and Mechanistic Investigation of Antitumor Compounds from Dioscorea nipponica Makino subsp. rosthornii Through Spectrum-Effect Relationship Analysis

At a Glance

CategoryDetail
ConditionNon-small cell lung cancer (A549 cells)
Key MechanismsInhibition of proliferation, migration, and invasion via downregulation of N-cadherin and MMP2 and upregulation of E-cadherin
Target PopulationPatients with lung cancer (preclinical cellular model)
Care SettingPreclinical research and potential future cancer therapy development

Key Highlights

  • UPLC-QTOF-MS identified 23 chemical constituents in 12 batches of D. nipponica Makino subsp. rosthornii.
  • Protodioscin, diosgenin, and gracillin were identified as key antitumor compounds through spectrum-effect relationship analysis.
  • These saponins inhibit malignant phenotypes of A549 cells by modulating expression of metastasis-related proteins.

Guideline-Based Recommendations

Diagnosis

  • Utilize chemical fingerprinting (UPLC-QTOF-MS) to characterize herbal extracts for active constituents.

Management

  • Consider Dioscorea nipponica Makino subsp. rosthornii extracts containing protodioscin, diosgenin, and gracillin as potential antitumor agents.
  • Target malignant cell proliferation, migration, and invasion pathways by modulating N-cadherin, MMP2, and E-cadherin expression.

Monitoring & Follow-up

  • Assess changes in protein expression levels of N-cadherin, MMP2, and E-cadherin to evaluate treatment efficacy in cellular models.

Risks

  • Further studies are required to establish safety and efficacy in clinical settings.

Patient & Prescribing Data

Preclinical lung cancer cellular models (A549 cells)

Extracts and isolated saponins from D. nipponica Makino subsp. rosthornii demonstrate inhibitory effects on lung cancer cell proliferation and metastasis-related behaviors.

Clinical Best Practices

  • Employ spectrum-effect relationship analysis to correlate chemical constituents with bioactivity in herbal medicines.
  • Validate identified active compounds through in vitro functional assays targeting cancer cell proliferation and metastasis.
  • Investigate molecular mechanisms focusing on metastasis-related protein expression to elucidate antitumor effects.

References

Original Source(s)

Related Content